Maryland Capital Management’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $9.69M | Buy |
112,477
+9,047
| +9% | +$808K | 0.81% | 42 |
|
|
2022
Q2 | $9.43M | Buy |
103,430
+5,162
| +5% | +$458K | 0.74% | 45 |
|
|
2022
Q1 | $8.06M | Buy |
98,268
+3,119
| +3% | +$246K | 0.51% | 56 |
|
|
2021
Q4 | $7.29M | Buy |
95,149
+2,399
| +3% | +$191K | 0.39% | 58 |
|
|
2021
Q3 | $6.97M | Sell |
92,750
-7,687
| -8% | -$585K | 0.42% | 56 |
|
|
2021
Q2 | $7.81M | Sell |
100,437
-1,179
| -1% | -$87.7K | 0.47% | 53 |
|
|
2021
Q1 | $7.47M | Buy |
101,616
+5,881
| +6% | +$434K | 0.5% | 52 |
|
|
2020
Q4 | $7.47M | Buy |
95,735
+9,386
| +11% | +$718K | 0.53% | 48 |
|
|
2020
Q3 | $6.83M | Buy |
86,349
+1,776
| +2% | +$139K | 0.56% | 44 |
|
|
2020
Q2 | $6.24M | Buy |
84,573
+4,886
| +6% | +$368K | 0.58% | 46 |
|
|
2020
Q1 | $5.85M | Buy |
79,687
+15,099
| +23% | +$1.19M | 0.69% | 44 |
|
|
2019
Q4 | $5.61M | Buy |
64,588
+3,676
| +6% | +$302K | 0.6% | 46 |
|
|
2019
Q3 | $4.89M | Buy |
60,912
+2,047
| +3% | +$164K | 0.56% | 48 |
|
|
2019
Q2 | $4.71M | Buy |
58,865
+4,650
| +9% | +$356K | 0.56% | 47 |
|
|
2019
Q1 | $4.3M | Buy |
54,215
+4,210
| +8% | +$315K | 0.53% | 52 |
|
|
2018
Q4 | $3.65M | Buy |
50,005
+2,467
| +5% | +$174K | 0.53% | 51 |
|
|
2018
Q3 | $3.22M | Buy |
47,538
+94
| +0.2% | +$5.99K | 0.42% | 54 |
|
|
2018
Q2 | $2.75M | Buy |
47,444
+388
| +0.8% | +$21.9K | 0.38% | 58 |
|
|
2018
Q1 | $2.45M | Buy |
47,056
+370
| +0.8% | +$20K | 0.35% | 60 |
|
|
2017
Q4 | $2.51M | Buy |
46,686
+2,410
| +5% | +$134K | 0.37% | 57 |
|
|
2017
Q3 | $2.71M | Buy |
44,276
+818
| +2% | +$49.6K | 0.42% | 54 |
|
|
2017
Q2 | $2.66M | Sell |
43,458
-10
| -0% | -$609 | 0.38% | 56 |
|
|
2017
Q1 | $2.63M | Sell |
43,468
-1,746
| -4% | -$106K | 0.39% | 57 |
|
|
2016
Q4 | $2.54M | Buy |
45,214
+1,756
| +4% | +$103K | 0.39% | 57 |
|
|
2016
Q3 | $2.59M | Buy |
43,458
+932
| +2% | +$54.5K | 0.39% | 53 |
|
|
2016
Q2 | $2.34M | Buy |
42,526
+1,405
| +3% | +$74.8K | 0.37% | 54 |
|
|
2016
Q1 | $2.08M | Buy |
41,121
+1,954
| +5% | +$95.7K | 0.3% | 58 |
|
|
2015
Q4 | $1.97M | Buy |
39,167
+2,269
| +6% | +$114K | 0.29% | 56 |
|
|
2015
Q3 | $1.74M | Buy |
36,898
+2,403
| +7% | +$128K | 0.29% | 58 |
|
|
2015
Q2 | $1.87M | Sell |
34,495
-736
| -2% | -$41.3K | 0.29% | 58 |
|
|
2015
Q1 | $1.93M | Buy |
35,231
+1,688
| +5% | +$95.6K | 0.3% | 57 |
|
|
2014
Q4 | $1.82M | Buy |
33,543
+842
| +3% | +$46.9K | 0.3% | 59 |
|
|
2014
Q3 | $1.85M | Buy |
32,701
+145
| +0.4% | +$8.14K | 0.32% | 60 |
|
|
2014
Q2 | $1.8M | Buy |
32,556
+257
| +0.8% | +$14K | 0.32% | 59 |
|
|
2014
Q1 | $1.75M | Sell |
32,299
-1,954
| -6% | -$101K | 0.32% | 60 |
|
|
2013
Q4 | $1.64M | Buy |
34,253
+2,965
| +9% | +$136K | 0.26% | 68 |
|
|
2013
Q3 | $1.42M | Sell |
31,288
-230
| -0.7% | -$10.5K | 0.23% | 71 |
|
|
2013
Q2 | $1.4M | Buy |
+31,518
| New | +$1.41M | 0.24% | 72 |
|
Other funds holding MRK
Maryland Capital Management's MRK Position: Q3 2022 in Review
Maryland Capital Management increased its Merck (MRK) stake by 8.7% in Q3 2022, buying an estimated $808K and bringing the position to 112,477 shares worth $9.69M. The position accounts for 0.81% of the portfolio, ranked #42.
Maryland Capital Management first reported a position in MRK in Q2 2013 and has held it in 38 quarters since. 2,989 funds tracked by Wall St. Rank hold MRK as of Q3 2022.
- Maryland Capital Management held 112,477 shares of Merck worth $9.69M as of Q3 2022.
- Maryland Capital Management bought 9,047 Merck shares in Q3 2022, an estimated $808K.
- Merck made up 0.81% of Maryland Capital Management's portfolio in Q3 2022, its #42 holding.
- Maryland Capital Management first reported a position in Merck in Q2 2013 and has held it in 38 quarters since.
- 2,989 funds tracked by Wall St. Rank held Merck as of Q3 2022.
Based on Maryland Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.